Sort
21,281 grants matching “influenza”
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Mix & Match DMID #21-0012 {Supplement #7}
$3,094,264David S Stephens · Emory University · UM1 · FY2021 · AI
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$3,088,985David Topham · University Of Rochester · N01 · FY2013 · AI
Vaccination and infection: indicators of immunological health and responsiveness
$3,087,546Mark M Davis · Stanford University · U19 · FY2012 · AI
Genomic Sequencing Center for Infectious Diseases
$3,085,322William Charles Nierman · J. Craig Venter Institute, Inc. · N01 · FY2010 · AI
The role of cryptic influenza virus proteins in replication and pathogenesis
$3,085,097Andrew Mehle · University Of Wisconsin-Madison · R01 · FY2025 · AI
TCR-dependent and epigenetic mechanisms guiding influenza-specific CD4+ T cell responses in the lung
$3,078,308Jeffrey Scott Hale · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,077,917Anna Karolina Palucka · Baylor Research Institute · U19 · FY2011 · AI
B Cell Biology
$3,076,055Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Animal Medicine COVID Support
$3,073,765Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIG · FY2020 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,072,123Donald K Milton · Univ Of Maryland, College Park · U19 · FY2024 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,072,035Donald K Milton · Univ Of Maryland, College Park · U19 · FY2023 · AI
Development of vaccines to bacterial diseases found especially in children
$3,071,596John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Systems Biological Analysis of Innate and Adaptive Responses to Vaccination
$3,068,402Bali Pulendran · Emory University · U19 · FY2012 · AI
Protective Mechanisms Against Pandemic Respiratory Virus
$3,066,309Ann M Arvin · Stanford University · U19 · FY2006 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,059,835Anna Karolina Palucka · Baylor Research Institute · U19 · FY2013 · AI
RAT21: Generation and Characterization of Rat Models of Down Syndrome
$3,057,165Michael E. Yeager · University Of Colorado Denver · R24 · FY2020 · HD
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus
$3,055,350Vanderbilt University · N01 · FY2009 · AI
Protective Mechanisms Against Pandemic Respiratory Virus
$3,054,173Ann M Arvin · Stanford University · U19 · FY2007 · AI
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,052,265Donald K Milton · Univ Of Maryland, College Park · U19 · FY2022 · AI
Development of a Nanoemulsion Adjuvant
$3,050,337Ali I. Fattom · Bluewillow Biologics, Inc. · N01 · FY2017 · AI
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$3,040,455Mark M Davis · Stanford University · U19 · FY2009 · AI
Influenza Vaccine Development
$3,038,369Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,034,833Anna Karolina Palucka · Baylor Research Institute · U19 · FY2012 · AI
Maternal Immunization and Determinants of Infant Immunity
$3,033,683Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2025 · AI
BD ProbeTec ET for Diagnosis of Influenza and SARS
$3,025,860Bd Diagnostics · UC1 · FY2004 · AI